-
Tunicamycin as a Precision ER Stress Comparator
2026-08-30
Tunicamycin is more than an N-glycosylation inhibitor: it is a defined comparator for separating general ER stress from stimulus-specific unfolded protein responses. This guide connects Tunicamycin assay design with new HAX1–SARS-CoV-2 spike findings and practical macrophage workflows.
-
A-769662: AMPK Activation Beyond Autophagy
2026-08-29
A-769662 is a reversible AMPK activator for dissecting energy metabolism, autophagy, and proteasome biology. This evidence-focused guide explains why AMPK activation does not always increase autophagy and how to design assays that separate pathway effects from compound-specific mechanisms.
-
Streptavidin-Cy3 Workflows for NPC Metastasis
2026-08-28
Build sensitive IHC, ISH, IF, and flow cytometry assays around a high-affinity streptavidin cy3 conjugate. This guide connects biotin-based detection to super-enhancer RNA and NDRG1 studies in nasopharyngeal carcinoma while emphasizing controls, optimization, and interpretation limits.
-
HyperScript III RT SuperMix for CRC RNA Stratification
2026-08-28
HyperScript III RT SuperMix supports reproducible gene expression analysis by qPCR when colorectal cancer RNA is scarce, GC-rich, or vulnerable to genomic DNA carryover. This article translates bile acid metabolism-based CRC findings into a practical assay-design and validation framework.
-
GSK343: Reliable EZH2 Assay Workflows
2026-08-27
Learn how GSK343 (SKU A3449) can improve the interpretation of cell viability, proliferation, and H3K27me3 assays through careful solvent control, concentration planning, and orthogonal validation. This scenario-based guide distinguishes biochemical potency from cellular response and defines practical limits for epigenetic cancer research.
-
Filipin III for Cholesterol Assay Design
2026-08-27
Filipin III provides a spatial view of membrane-associated cholesterol that can sharpen interpretation of macrophage lipid dysregulation. This guide connects cholesterol detection in membranes with SOAT1-driven lipophagy failure and pulmonary fibrosis research while defining practical controls and limitations.
-
Ozone, Efferocytosis, and Neuropathic Pain
2026-08-26
A 2024 Frontiers in Immunology study identifies macrophage efferocytosis as a modifiable component of neuropathic pain and links ozone treatment to the AMPK/Gas6-MerTK/SOCS3 pathway. In chronic constriction injury mice and bone-marrow-derived macrophages, ozone improved apoptotic-cell clearance, reduced inflammatory signaling, and alleviated mechanical hypersensitivity, while pharmacological pathway inhibition weakened these effects.
-
Fluoroalkane Polymers for mRNA Cancer Vaccines
2026-08-26
The reference study introduces fluoroalkane-grafted polyethylenimine (F-PEI) as a relatively simple carrier for therapeutic mRNA. Its self-assembled nanovaccines improved intracellular delivery, promoted TLR4-associated dendritic-cell activation and antigen presentation, and produced antitumor activity in ovalbumin and neoantigen mouse models, particularly when combined with immune checkpoint blockade.
-
Cisapride (R 51619) in Cardiac Screening
2026-08-25
Cisapride (R 51619) connects 5-HT4 receptor biology with hERG-linked cardiac risk in iPSC-cardiomyocyte workflows. This guide translates high-content imaging, electrophysiology, and troubleshooting principles into a practical assay strategy for cardiac arrhythmia research.
-
NSC 87877: Practical Shp2 Inhibitor Workflows
2026-08-25
NSC 87877 is a potent Shp2 inhibitor for separating phosphatase-dependent signaling from upstream receptor events in EGF, microglial, leukemia, and inflammatory pain models. This guide converts SHP2–NLRP3 findings from ischemic-stroke research into practical assay designs, controls, and troubleshooting strategies.
-
17-AAG and HSP90: Assay-Ready Cancer Biology
2026-08-24
17-AAG (Tanespimycin) provides a powerful way to interrogate HSP90-dependent oncogenic signaling, client-protein stability, and apoptosis. This article combines cancer biology with assay lessons from a landmark NINJ1–norovirus study to improve causal interpretation without overstating cross-domain evidence.
-
PID1, Oxysterols, and Macrophage Fate in Cancer
2026-08-24
The reference study identifies PID1 as an immunometabolic checkpoint that controls LDL uptake, cholesterol oxidation, and tumor-associated macrophage state. Its findings suggest that redirecting sterol metabolism toward 5α,6α-epoxycholesterol and 7β-hydroxycholesterol can improve CD8+ T-cell surveillance and enhance 5-fluorouracil responses.
-
SARS-CoV-2 N Protein, GADD34, and Atypical Foci
2026-08-23
The reference study identifies a stress-granule-associated mechanism by which SARS-CoV-2 nucleocapsid protein suppresses GADD34-dependent innate immunity. Its central finding is that nucleocapsid-driven N+/G3BP1+ atypical foci sequester GADD34 mRNA, impair IRF3 nuclear localization, and support viral replication.
-
Ricin-Triggered Bystander Necroptosis in Lung Epithelium
2026-08-22
Kempen and colleagues demonstrate that ricin-injured monocytic cells can transmit a soluble death signal to lung epithelial cells, converting primary toxin injury into bystander necroptosis. Their U937-to-A549 model identifies released ricin, Fas ligand, HMGB1, RAGE signaling, and reactive oxygen species as components of this inflammatory cascade, with implications for interpreting toxin-associated lung damage.
-
Gastrin I (Human): From Receptor Biology to Translation
2026-08-22
A translational framework for using Gastrin I (human) to connect CCK2 receptor signaling and proton pump activation with human-relevant gastric and intestinal models, including hiPSC-derived organoids for gastrointestinal physiology studies, pharmacokinetic evaluation, and gastrointestinal disorder research.